Alpha-tocopheryl Succinate Sensitises a T Lymphoma Cell Line to TRAIL-induced Apoptosis by Suppressing NF-kappaB Activation

Overview

Journal Br J Cancer

Specialty Oncology

Date 2003 Jan 31

PMID 12556975

Citations 14

Authors

H Dalen

J Neuzil

Affiliations

Soon will be listed here.

Abstract

Activation of nuclear factor-kappaB (NF-kappaB) can interfere with induction of apoptosis triggered by the tumour necrosis factor-related apoptosis-inducing ligand (TRAIL; Apo2L). Therefore, agents that suppress NF-kappaB activation may sensitise cells to TRAIL-dependent apoptosis. Exposure of Jurkat cells to TRAIL resulted in massive and saturable apoptosis induction, following an initial lag time. This lag was abolished by pretreatment of the cells with subapoptotic doses of alpha-tocopheryl succinate (alpha-TOS) or the proteasome inhibitor MG132. Exposure of the cells to TRAIL led to a rapid, transient activation of NF-kappaB, a process that was suppressed by cell pretreatment with alpha-TOS or MG132. Activation of NF-kappaB by TNF-alpha prior to TRAIL exposure increased resistance of the cells to TRAIL-mediated apoptosis. We conclude that alpha-TOS sensitises cells to TRAIL killing, at least in some cases, through inhibition of NF-kappaB activation. This further supports the possibility that this semisynthetic analogue of vitamin E is a potential adjuvant in cancer treatment, such as in the case of TRAIL-mediated inhibition of cancer.

Citing Articles

An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management.

Khallouki F, Hajji L, Saber S, Bouddine T, Edderkaoui M, Bourhia M J Pers Med. 2023; 13(5).

PMID: 37240924 PMC: 10221210. DOI: 10.3390/jpm13050754.

Synthesis, characterization and apoptotic activity of quinazolinone Schiff base derivatives toward MCF-7 cells via intrinsic and extrinsic apoptosis pathways.

Zahedifard M, Faraj F, Paydar M, Looi C, Hajrezaei M, Hasanpourghadi M Sci Rep. 2015; 5:11544.

PMID: 26108872 PMC: 4479988. DOI: 10.1038/srep11544.

Synthesis, characterization, and anticancer activity of new quinazoline derivatives against MCF-7 cells.

Faraj F, Zahedifard M, Paydar M, Looi C, Abdul Majid N, Ali H ScientificWorldJournal. 2014; 2014:212096.

PMID: 25548779 PMC: 4274848. DOI: 10.1155/2014/212096.

Nanomicellar carriers for targeted delivery of anticancer agents.

Zhang X, Huang Y, Li S Ther Deliv. 2013; 5(1):53-68.

PMID: 24341817 PMC: 3913259. DOI: 10.4155/tde.13.135.

TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame.

Farooqi A, Bhatti S, Ismail M Cancer Cell Int. 2012; 12(1):22.

PMID: 22672528 PMC: 3502079. DOI: 10.1186/1475-2867-12-22.

References

Ashkenazi A, Dixit V . Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999; 11(2):255-60. DOI: 10.1016/s0955-0674(99)80034-9. View

Bodmer J, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P . TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol. 2000; 2(4):241-3. DOI: 10.1038/35008667. View

Kreuz S, Siegmund D, Scheurich P, Wajant H . NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol. 2001; 21(12):3964-73. PMC: 87059. DOI: 10.1128/MCB.21.12.3964-3973.2001. View

Neuzil J, Kagedal K, Andera L, Weber C, Brunk U . Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and anti-atherogenic activity. Apoptosis. 2002; 7(2):179-87. DOI: 10.1023/a:1014378901843. View

Nesterov A, Ivashchenko Y, Kraft A . Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene. 2002; 21(7):1135-40. DOI: 10.1038/sj.onc.1205151. View

Kischkel F, Lawrence D, Chuntharapai A, Schow P, Kim K, Ashkenazi A . Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity. 2000; 12(6):611-20. DOI: 10.1016/s1074-7613(00)80212-5. View

Bonavida B, Ng C, Jazirehi A, Schiller G, Mizutani Y . Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: the trail to non-toxic cancer therapeutics (review). Int J Oncol. 1999; 15(4):793-802. DOI: 10.3892/ijo.15.4.793. View

Plasilova M, Zivny J, Jelinek J, Neuwirtova R, cermak J, Necas E . TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors. Leukemia. 2002; 16(1):67-73. DOI: 10.1038/sj.leu.2402338. View

Neuzil J, Weber T, Gellert N, Weber C . Selective cancer cell killing by alpha-tocopheryl succinate. Br J Cancer. 2001; 84(1):87-9. PMC: 2363620. DOI: 10.1054/bjoc.2000.1559. View

10.

Walczak H, Bouchon A, Stahl H, Krammer P . Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Cancer Res. 2000; 60(11):3051-7. View

11.

Schneider P, Bodmer J, Thome M, Hofmann K, Holler N, Tschopp J . Characterization of two receptors for TRAIL. FEBS Lett. 1997; 416(3):329-34. DOI: 10.1016/s0014-5793(97)01231-3. View

12.

Pan G, Ni J, Wei Y, Yu G, Gentz R, Dixit V . An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science. 1997; 277(5327):815-8. DOI: 10.1126/science.277.5327.815. View

13.

Malafa M, Fokum F, Mowlavi A, Abusief M, King M . Vitamin E inhibits melanoma growth in mice. Surgery. 2002; 131(1):85-91. DOI: 10.1067/msy.2002.119191. View

14.

Franco A, Zhang X, Van Berkel E, Sanders J, Zhang X, Thomas W . The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells. J Immunol. 2001; 166(9):5337-45. DOI: 10.4049/jimmunol.166.9.5337. View

15.

Neuzil J, Svensson I, Weber T, Weber C, Brunk U . alpha-tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS Lett. 1999; 445(2-3):295-300. DOI: 10.1016/s0014-5793(99)00141-6. View

16.

Keogh S, Walczak H, Bouchier-Hayes L, Martin S . Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis. FEBS Lett. 2000; 471(1):93-8. DOI: 10.1016/s0014-5793(00)01375-2. View

17.

Hopkins-Donaldson S, Bodmer J, Bourloud K, Brognara C, Tschopp J, Gross N . Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 2000; 60(16):4315-9. View

18.

Muhlenbeck F, Haas E, Schwenzer R, Schubert G, Grell M, Smith C . TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways. J Biol Chem. 1998; 273(49):33091-8. DOI: 10.1074/jbc.273.49.33091. View

19.

Chinery R, Brockman J, Peeler M, Shyr Y, Beauchamp R, Coffey R . Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta. Nat Med. 1997; 3(11):1233-41. DOI: 10.1038/nm1197-1233. View

20.

Suliman A, Lam A, Datta R, Srivastava R . Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene. 2001; 20(17):2122-33. DOI: 10.1038/sj.onc.1204282. View